Exosomes, cell-derived extracellular vesicles measuring 30-150 nm, hold immense potential in treating chronic conditions, including autoimmune disorders. Their therapeutic applicability has positioned them as potential drug carriers. In the field of cancer, exosomes play significant roles in metastasis, drug resistance, and angiogenesis. This market overview delves into the expanding landscape of exosomes, highlighting their diverse applications and promising potential for revolutionizing therapeutic interventions.
According to Data Bridge Market Research, the Exosome Therapeutics Market accounted for USD 550.58 thousand in 2022, would rise to USD 1,986.86 thousand by 2030 and is expected to undergo a CAGR of 17.40% during the forecast period 2023 to 2030.
“Growing R&D activities associated with exosome research”
The exponential growth in the number of published articles on exosomes indicates the increasing interest and research activities in the field. With over 4400 articles published and a significant portion in recent years, it reflects the expanding knowledge and exploration of exosomal research. This surge is accompanied by the involvement of numerous companies and increased funding, which further accelerates the advancement and industrial growth in the field of exosomes.
What restraints the growth of exosome therapeutics market?
“Contamination allied with exosomes”
Contamination issues pose a significant challenge to the growth of the exosome market. Improper extraction and sterilization of exosomes can result in the presence of intracellular or extracellular genetic material, which can have harmful effects. The introduction of this genetic material to cells can lead to incorrect signaling, potentially causing abnormal cell development at the target site or other parts of the body. Consequently, these contamination concerns become a hindrance to market expansion and require stringent quality control measures.
Segmentation: Exosome Therapeutics Market
The exosome therapeutics market is segmented on the basis of type, source, therapy, transporting capacity, application, route of administration, and end user.
- On the basis of type, the exosome therapeutics market is segmented into natural exosome, and hybrid exosome.
- On the basis of source, the exosome therapeutics market is segmented into mesenchymal stem cells, blood, body fluids, urine, dendritic cells, saliva, milk, and others.
- On the basis of therapy, the exosome therapeutics market is segmented into immunotherapy, chemotherapy, and gene therapy.
- On the basis of transporting, capacity the exosome therapeutics market is segmented into bio macromolecules and small molecules.
- On the basis of application, the exosome therapeutics market is segmented into metabolic disorders, oncology, cardiac disorders, neurology, inflammatory disorders, organ transplantation, gynecology disorders, blood disorders, and others.
- On the basis of the route, of administration the exosome therapeutics market is segmented into parenteral and oral.
- On the basis of end user, the exosome therapeutics market is segmented into research and academic institutes, hospitals, and diagnostic centers.
Regional Insights: North America dominates the Exosome Therapeutics Market
North America exhibits dominance in the exosome therapeutics market, driven by factors such as the widespread presence of FDA-approved wound debridement devices, favorable health remuneration policies, a rise in chronic wounds, and a growing elderly population. Additionally, the market benefits from the strong performance of the natural exosomes segment, further fueling its growth.
The Asia-Pacific region is expected to witness the highest growth rate during the forecast period from 2023 to 2030. This growth can be attributed to increasing healthcare infrastructure expenditures, rising investments in research and development activities, and government focus on healthcare. Furthermore, the region's market growth is fueled by the growing awareness of treatment options, incidence of infectious diseases, and ongoing clinical trials.
To know more about the study visit, https://www.databridgemarketresearch.com/fr/reports/global-exosome-therapeutic-market
Recent Developments in Exosome Therapeutics Market
- In 2021, Johns Hopkins University and Capricor Therapeutics entered into an agreement to expand the exosome platform technology portfolio. As part of the company's exosome technology portfolio, this expansion includes engineered exosomes for vaccines and therapeutics. With this agreement, Capricor Therapeutics gains worldwide rights to utilize exosomes for the development of vaccines and therapeutics. This collaboration opens up new possibilities for leveraging exosome technology in the field of medical research and advancing the development of innovative treatments.
The Prominent Key Players Operating in the Exosome Therapeutics Market Include:
- Church & Dwight Co., Inc. (U.S.)
- GSK plc. (U.K.)
- Pfizer Inc. (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
- Takeda Pharmaceutical Company Limited (Japan)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Novartis AG (Switzerland), Lily. (U.S.
- AstraZeneca (U.S.)
- Boehringer Ingelheim International GmbH (Germany)
- CELGENE CORPORATION (U.S.)
- Sanofi (France)
- Johnson & Johnson Services, Inc. (U.S.)
- Dr. Reddy's Laboratories Ltd. (India),
- Teva Pharmaceutical Industries Ltd. (Israel)
- Bristol-Myers Squibb Company (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of exosome therapeutics market companies contact, https://www.databridgemarketresearch.com/fr/contact
Research Methodology: Global Exosome Therapeutics Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
